BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23668474)

  • 1. Pathogenesis of infantile haemangioma.
    Greenberger S; Bischoff J
    Br J Dermatol; 2013 Jul; 169(1):12-9. PubMed ID: 23668474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infantile haemangiomas: a challenge in paediatric dermatology.
    Schwartz RA; Sidor MI; Musumeci ML; Lin RL; Micali G
    J Eur Acad Dermatol Venereol; 2010 Jun; 24(6):631-8. PubMed ID: 20565561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infantile haemangioma: a complicated disease.
    Qiu M; Qi X; Dai Y; Wang S; Quan Z; Liu Y; Ou J
    Front Biosci (Landmark Ed); 2015 Jun; 20(7):1004-16. PubMed ID: 25961539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of treating infantile haemangioma with propranolol in an outpatient setting.
    Chaturvedi K; Steinberg JS; Snyder CS
    Cardiol Young; 2018 Oct; 28(10):1105-1108. PubMed ID: 30047346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Propranolol as first-line treatment for rapidly proliferating infantile haemangiomas.
    Holmes WJ; Mishra A; Gorst C; Liew SH
    J Plast Reconstr Aesthet Surg; 2011 Apr; 64(4):445-51. PubMed ID: 20797926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile haemangioma.
    Léauté-Labrèze C; Harper JI; Hoeger PH
    Lancet; 2017 Jul; 390(10089):85-94. PubMed ID: 28089471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution.
    Itinteang T; Brasch HD; Tan ST; Day DJ
    J Plast Reconstr Aesthet Surg; 2011 Jun; 64(6):759-65. PubMed ID: 20870476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical treatment of children with infantile haemangiomas].
    Velure HK; Hartling UB; Schuster A; Bygum A
    Ugeskr Laeger; 2017 Feb; 179(8):. PubMed ID: 28397661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Infantile haemangioma: clinical and demographic characteristics, experiences in the treatment].
    Csoma ZR; Dalmády S; Ábrahám R; Rózsa T; Rácz K; Kemény L
    Orv Hetil; 2017 Oct; 158(39):1535-1544. PubMed ID: 28942665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action.
    Ji Y; Chen S; Xu C; Li L; Xiang B
    Br J Dermatol; 2015 Jan; 172(1):24-32. PubMed ID: 25196392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Thrombospondin-1 and Nuclear Factor-κB Signaling Pathways in Antiangiogenesis of Infantile Hemangioma.
    Xu W; Li S; Yu F; Zhang Y; Yang X; An W; Wang W; Sun C
    Plast Reconstr Surg; 2018 Sep; 142(3):310e-321e. PubMed ID: 30148773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Propranolol therapy for periocular and orbital infantile haemangiomas].
    Sterker I; Tegetmeyer H; Sorge I; Weißer M; Böhm R
    Klin Monbl Augenheilkd; 2014 Oct; 231(10):971-9. PubMed ID: 25333232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemangioma: clinical course, complications and management.
    Luu M; Frieden IJ
    Br J Dermatol; 2013 Jul; 169(1):20-30. PubMed ID: 23701395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic and Angiogenic Activity of Circulating Endothelial Colony Forming Cells in Patients with Infantile Haemangioma Receiving Propranolol.
    Campanelli R; Codazzi AC; Poletto V; Abbà C; Catarsi P; Fois G; Avanzini MA; Brazzelli V; Tzialla C; De Silvestri A; Tinelli C; Licari A; Berra-Romani R; Zuccolo E; Moccia F; Mannarino S; Rosti V; Massa M
    Thromb Haemost; 2019 Feb; 119(2):274-284. PubMed ID: 30609443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infantile hemangiomas: what have we learned from propranolol?
    Hagen R; Ghareeb E; Jalali O; Zinn Z
    Curr Opin Pediatr; 2018 Aug; 30(4):499-504. PubMed ID: 29846253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic corticosteroid is effective and safe treatment for problematic infantile hemangioma.
    Greene AK
    Pediatr Dermatol; 2010; 27(3):322-3. PubMed ID: 20609168
    [No Abstract]   [Full Text] [Related]  

  • 17. Infantile haemangioma: new aspects on the pathogenesis of the most common skin tumour in children.
    Hoeger PH
    Br J Dermatol; 2011 Feb; 164(2):234-5. PubMed ID: 21271990
    [No Abstract]   [Full Text] [Related]  

  • 18. [Infantile haemangioma: an update].
    Reimer A; Ott H
    Hautarzt; 2019 Jun; 70(6):447-458. PubMed ID: 31101924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A potential role for notch signaling in the pathogenesis and regulation of hemangiomas.
    Wu JK; Kitajewski JK
    J Craniofac Surg; 2009 Mar; 20 Suppl 1(0 1):698-702. PubMed ID: 19169152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in the management of periorbital infantile haemangioma.
    Cheng JF; Gole GA; Sullivan TJ
    Clin Exp Ophthalmol; 2010 Aug; 38(6):547-53. PubMed ID: 20553300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.